CHOLECYSTECTOMY IN A MAN WITH HEMOPHILIA A AND INHIBITOR ON EMICIZUMAB PROPHYLAXIS: A CASE REPORT

CHOLECYSTECTOMY IN A MAN WITH HEMOPHILIA A AND INHIBITOR ON EMICIZUMAB PROPHYLAXIS: A CASE REPORT

There are few reports about the hemostatic effectiveness and safety of emicizumab on major surgeries, especially non-orthopedic ones. We described a man with severe hemophilia A and high-responding inhibitor under emicizumab prophylaxis who was submitted to an open cholecystectomy due to acute-on-ch...

Full description

Bibliographic Details
Main Authors:	PC Giacometto, MT Bavaresco, RCM Molina, J Alvares-Teodoro, RM Camelo
Format:	Article
Language:	English
Published:	Elsevier 2021-10-01
Series:	Hematology, Transfusion and Cell Therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2531137921005228

Similar Items

BRAZILIAN REGISTRY OF PERSONS WITH HEMOPHILIA A RECEIVING EMICIZUMAB (EMICIZUMAB CASES, EMCASE PROJECT)
by: R.M. Camelo, et al.
Published: (2020-11-01)

SIX MONTHS OF EMICIZUMAB PROPHYLAXIS IN A WOMAN WITH MILD HEMOPHILIA A AND INHIBITOR: EFFECTIVENESS, ECONOMIC OUTCOME, AND SAFETY
by: R.M. Camelo, et al.
Published: (2020-11-01)

DRAWBACKS OF PERSONALIZATION OF PROPHYLAXIS AMONG ADULT MEN WITH HEMOPHILIA A
by: PC Giacometto, et al.
Published: (2021-10-01)

PHARMACOKINETIC-GUIDED PROPHYLAXIS FOR PEOPLE WITH HEMOPHILIA A
by: ACO Borges, et al.
Published: (2021-10-01)

Twelve months of emicizumab prophylaxis in a severe hemophilia A man with inhibitor who failed immune tolerance induction: effectiveness, economic, and safety outcomes
by: Ricardo Mesquita Camelo, et al.
Published: (2023-01-01)

Emicizumab prophylaxis for people with hemophilia A: Waste estimation and the Brazilian perspective
by: Ricardo Mesquita Camelo, et al.
Published: (2023-12-01)

TWELVE MONTHS OF EMICIZUMAB PROPHYLAXIS IN A SEVERE HAEMOPHILIA A MAN WITH INHIBITOR WHO FAILED IMMUNE TOLERANCE INDUCTIONS: EFFECTIVENESS, ECONOMIC OUTCOME, AND SAFETY
by: R.M. Camelo, et al.
Published: (2020-11-01)

Cerebellar hematoma in severe hemophilia with inhibitor on emicizumab prophylaxis: a case report
by: Sami Albattat, et al.
Published: (2023-02-01)

Emicizumab in the treatment of hemophilia A
by: Tijanić Ivan R., et al.
Published: (2020-01-01)

Surgical Experience from the STASEY Study of Emicizumab Prophylaxis in People with Hemophilia A with Factor VIII Inhibitors
by: Giancarlo Castaman, et al.
Published: (2024-01-01)

TAXAS ANUALIZADAS DE SANGRAMENTO DURANTE O PRIMEIRO ANO DE PROFILAXIA COM EMICIZUMABE: RESULTADOS PRELIMINARES DO REGISTRO NACIONAL DE EMICIZUMABE (PROJETO EMCASE)
by: LCM Henriques, et al.
Published: (2023-10-01)

Emicizumab Associated Rhabdomyolysis in Hemophilia A
by: Joseph A. Wilson, et al.
Published: (2020-10-01)

Initial experience of Emicizumab prophylaxis in children with inhibitor positive severe hemophilia A from a single center in India
by: Nita Radhakrishnan, et al.
Published: (2021-06-01)

Emicizumab Prophylaxis in Patients with Severe Hemophilia A: Insights from A Resource Limited Country
by: Munira Borhany MD, et al.
Published: (2024-01-01)

Management and Outcomes of Invasive Procedures in Individuals with Hemophilia A on Emicizumab Prophylaxis: A Single Center Experience
by: Karla Rener, et al.
Published: (2023-11-01)

Evaluation of safety and efficacy of Emicizumab prophylaxis in Egyptian pediatric patients with Hemophilia A: Single center experience
by: Marwa Zakaria, et al.
Published: (2023-01-01)

Real-world experience of emicizumab prophylaxis in young children with hemophilia A: retrospective data from China
by: Guoqing Liu, et al.
Published: (2022-10-01)

Cost-effectiveness study of prophylaxis with emicizumab versus bypassing agents in patients with severe hemophilia A in Peru
by: Ricardo Bitrán, et al.
Published: (2022-03-01)

P1616: EMICIZUMAB FOR THE MANAGEMENT OF ACQUIRED HEMOPHILIA A
by: Meera Sridharan, et al.
Published: (2023-08-01)

Expert opinion paper on the treatment of hemophilia A with emicizumab
by: Francisco-José López-Jaime, et al.
Published: (2023-12-01)

THE USE OF EMICIZUMAB IN A CHILD WITH HEMOPHILIA A INHIBITORY FOREMA
by: Юлия Олеговна Рождественская, et al.
Published: (2023-02-01)

Emicizumab in hemophilia A with inhibitors: clinical and economic impact of its use in a Cuban patient
by: Dunia Castillo-Gonzàles, et al.
Published: (2022-09-01)

Traumatic Tonsillar Hemorrhage during Hemophilia A Treatment with Emicizumab
by: Fumiya Inoue, et al.
Published: (2022-03-01)

Management of children with hemophilia A on emicizumab who need surgery
by: Mark Belletrutti, et al.
Published: (2023-04-01)

Disruptive technology and hemophilia care: The multiple impacts of emicizumab
by: Cedric Hermans, et al.
Published: (2021-05-01)

Emicizumab in tolerized patients with hemophilia A with inhibitors: A single‐institution pediatric cohort assessing inhibitor status
by: Glaivy Batsuli, et al.
Published: (2021-02-01)

Emicizumab initiation and bleeding outcomes in people with hemophilia A with and without inhibitors: A single‐center report
by: Beth Boulden Warren, et al.
Published: (2021-07-01)

Management of Urgent Bleeding in Patients with Hemophilia A: Focus on the Use of Emicizumab
by: Víctor Jiménez-Yuste, et al.
Published: (2024-04-01)

Emicizumab for acquired hemophilia A: Report of two cases and dosing strategies
by: Faiza Ahmed, et al.
Published: (2024-04-01)

Spotlight on emicizumab in the management of hemophilia A: patient selection and special considerations
by: Yada K, et al.
Published: (2019-07-01)

The effect of emicizumab and bypassing agents in patients with hemophilia – An in vitro study
by: Nina Haagenrud Schultz, et al.
Published: (2021-07-01)

PB2643: EFFICACY OF REDUCED-DOSE EMICIZUMAB IN HEMOPHILIA A WITH INHIBITORS: REAL WORLD EXPERIENCE IN MALAYSIA
by: Andy Sing Ong Tang, et al.
Published: (2023-08-01)

Management of perioperative hemostasis in a severe hemophilia A patient with inhibitors on emicizumab using global hemostasis assays
by: Hande Kizilocak, et al.
Published: (2019-06-01)

Successful Perioperative Combination of High-Dose FVIII Therapy Followed by Emicizumab in a Patient with Hemophilia A with Inhibitors
by: Shuichi Okamoto, et al.
Published: (2019-10-01)

Challenges in prophylactic therapy with Emicizumab in patients with hemophilia A: Focus on monitoring tests
by: Brinza Melen, et al.
Published: (2024-01-01)

Real-World Data on Bleeding Patterns of Hemophilia A Patients Treated with Emicizumab
by: Sarina Levy-Mendelovich, et al.
Published: (2021-09-01)

Concomitant Use of rFVIIa and Emicizumab in People with Hemophilia A with Inhibitors: Current Perspectives and Emerging Clinical Evidence
by: Linari S, et al.
Published: (2020-05-01)

PB2647: USE OF EMICIZUMAB FOR THE TREATMENT OF ACQUIRED HEMOPHILIA A: A SYSTEMATIC REVIEW
by: Zainab Al-Housni, et al.
Published: (2023-08-01)

Regression Analysis to Estimate the Factor VIII Activity of Patients with Hemophilia A Without Inhibitor who Received Emicizumab Therapy
by: Yuki Hatayama PhD, et al.
Published: (2022-02-01)

Absence of Effect of Emicizumab on D-Dimer Concentrations in Adult Patients with Severe Hemophilia A
by: Michael Iarossi MD, et al.
Published: (2022-12-01)